These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

377 related articles for article (PubMed ID: 9385331)

  • 21. Childhood immunizations: position on the enhanced inactivated poliovirus vaccine and live attenuated oral poliovirus vaccine dilemma.
    Willis E; Sherrod JL
    J Natl Med Assoc; 1997 Dec; 89(12):785-9. PubMed ID: 9433057
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Updated recommendations of the Advisory Committee on Immunization Practices (ACIP) regarding routine poliovirus vaccination.
    Centers for Disease Control and Prevention (CDC)
    MMWR Morb Mortal Wkly Rep; 2009 Aug; 58(30):829-30. PubMed ID: 19661857
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Poliovirus immunizations. What goes around, comes around.
    Soto NE; Lutwick LI
    Infect Dis Clin North Am; 1999 Mar; 13(1):265-78, ix. PubMed ID: 10198803
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Vaccine policy changes and epidemiology of poliomyelitis in the United States.
    Alexander LN; Seward JF; Santibanez TA; Pallansch MA; Kew OM; Prevots DR; Strebel PM; Cono J; Wharton M; Orenstein WA; Sutter RW
    JAMA; 2004 Oct; 292(14):1696-701. PubMed ID: 15479934
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Poliomyelitis prevention: recommendations for use of inactivated poliovirus vaccine and live oral poliovirus vaccine. American Academy of Pediatrics Committee on Infectious Diseases.
    Pediatrics; 1997 Feb; 99(2):300-5. PubMed ID: 9024465
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Cost-effectiveness of incorporating inactivated poliovirus vaccine into the routine childhood immunization schedule.
    Miller MA; Sutter RW; Strebel PM; Hadler SC
    JAMA; 1996 Sep; 276(12):967-71. PubMed ID: 8805731
    [TBL] [Abstract][Full Text] [Related]  

  • 27. World wide experience with inactivated poliovirus vaccine.
    Bonnet MC; Dutta A
    Vaccine; 2008 Sep; 26(39):4978-83. PubMed ID: 18680777
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Need for polio boosters after age two years.
    Rennels MB
    Vaccine; 2009 Jan; 27(2):179-80. PubMed ID: 19007837
    [No Abstract]   [Full Text] [Related]  

  • 29. Polio eradication: the OPV paradox.
    Dowdle WR; De Gourville E; Kew OM; Pallansch MA; Wood DJ
    Rev Med Virol; 2003; 13(5):277-91. PubMed ID: 12931339
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Current poliomyelitis immunization policy in the United States.
    Sutter RW; Onorato IM; Patriarca PA
    Pediatr Ann; 1990 Dec; 19(12):702-6. PubMed ID: 2177873
    [No Abstract]   [Full Text] [Related]  

  • 31. Poliomyelitis prevention: enhanced-potency inactivated poliomyelitis vaccine--supplementary statement.
    Centers for Disease Control (CDC)
    MMWR Morb Mortal Wkly Rep; 1987 Dec; 36(48):795-8. PubMed ID: 3119980
    [No Abstract]   [Full Text] [Related]  

  • 32. Recommendations of the Advisory Committee on Immunization Practices: revised recommendations for routine poliomyelitis vaccination.
    Centers for Disease Control and Prevention (CDC)
    MMWR Morb Mortal Wkly Rep; 1999 Jul; 48(27):590. PubMed ID: 10428098
    [No Abstract]   [Full Text] [Related]  

  • 33. Leads from the MMWR. Poliomyelitis prevention: enhanced-potency inactivated poliomyelitis vaccine--supplementary statement.
    JAMA; 1988 Jan; 259(3):345-6. PubMed ID: 3336150
    [No Abstract]   [Full Text] [Related]  

  • 34. Re: world wide experience with inactivated poliovirus vaccine.
    Arya SC; Agarwal N
    Vaccine; 2009 Jan; 27(1):1. PubMed ID: 18952133
    [No Abstract]   [Full Text] [Related]  

  • 35. Modeling the potential role of inactivated poliovirus vaccine to manage the risks of oral poliovirus vaccine cessation.
    Duintjer Tebbens RJ; Thompson KM
    J Infect Dis; 2014 Nov; 210 Suppl 1():S485-97. PubMed ID: 25316871
    [TBL] [Abstract][Full Text] [Related]  

  • 36. OPV vs IPV--could placental immunity reduce the number of vaccine-associated paralytic poliomyelitis?
    Fescharek R; Budde RK; Arras C
    Vaccine; 1997 Nov; 15(16):1707-8. PubMed ID: 9364670
    [No Abstract]   [Full Text] [Related]  

  • 37. Risks associated with the use of live-attenuated vaccine poliovirus strains and the strategies for control and eradication of paralytic poliomyelitis.
    Pliaka V; Kyriakopoulou Z; Markoulatos P
    Expert Rev Vaccines; 2012 May; 11(5):609-28. PubMed ID: 22827246
    [TBL] [Abstract][Full Text] [Related]  

  • 38. From the Centers for Disease Control and Prevention. Revised recommendations for routine poliomyelitis vaccination.
    JAMA; 1999 Aug; 282(6):522. PubMed ID: 10450703
    [No Abstract]   [Full Text] [Related]  

  • 39. Poliovirus vaccination.
    John TJ
    Lancet; 1993 Aug; 342(8867):370-1. PubMed ID: 8101609
    [No Abstract]   [Full Text] [Related]  

  • 40. [Poliomyelitis: new revelations, renewed polemics and the Hungarian experiences].
    Dömök I
    Orv Hetil; 1983 Jun; 124(23):1355-67. PubMed ID: 6877813
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 19.